FDA Inspection 1320914 — John James Mitchell, FRCPC, MD, MSc
The FDA completed an inspection of John James Mitchell, FRCPC, MD, MSc on May 28, 2026 in Montreal. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 28, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Montreal (Canada)
Additional Details
Clinical Investigator (CI)